Trafalgar International GCAN
OTC GCAN
$0.35 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Trafalgar International (GCAN) Non-Current Debt (2020 - 2023)

Trafalgar International (GCAN) posted Non-Current Debt of $36000.0 for Q3 2023, down 73.33% on a QoQ basis from $135000.0 in Q3 2022, and down 73.33% year-over-year from $135000.0 in Q3 2022.

Analysis

Trafalgar International (GCAN) Non-Current Debt (2020 - 2023) Analysis & Trends

Trafalgar International has reported Non-Current Debt for 4 years, with the latest figure at $36000.0 in Q3 2023.

  • On a quarterly basis, Non-Current Debt fell 73.33% year-over-year to $36000.0 in Q3 2023; TTM through Sep 2023 was $36000.0, a 73.33% decrease from a year earlier, with the FY2020 full-year figure at $325212.0, changed N/A from the prior year.
  • Non-Current Debt was $36000.0 for Q3 2023 at Trafalgar International, down from $135000.0 in the prior quarter.
  • The five-year high for Non-Current Debt was $325212.0 in Q4 2020, with the low at $22500.0 in Q1 2021.
  • Average Non-Current Debt over 4 years is $146532.6, with a median of $101041.0 recorded in 2020.
  • The largest YoY upside for Non-Current Debt was 0.0% in 2021 against a maximum downside of 86.39% in 2021.
  • Over 4 years, Non-Current Debt stood at $325212.0 in 2020, then declined by 4.35% to $311050.0 in 2021, then plunged by 56.6% to $135000.0 in 2022, then plunged by 73.33% to $36000.0 in 2023.
  • The last three Non-Current Debt figures came in at $36000.0 (Q3 2023), $135000.0 (Q3 2022), and $25000.0 (Q2 2022), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Johnson & Johnson 643.26 Bn 622.50 Bn 17.26 Bn 37.34 Bn
2 AbbVie 443.31 Bn 436.74 Bn 12.70 Bn 62.48 Bn
3 Merck 364.74 Bn 357.60 Bn 12.21 Bn 51.08 Bn
4 Novartis Ag 266.46 Bn 258.77 Bn 11.24 Bn -
5 Pfizer 158.57 Bn 146.88 Bn 10.94 Bn 60.50 Bn
6 Sanofi 52.33 Bn 44.95 Bn 10.79 Bn 17.02 Bn
7 Revolution Medicines 43.79 Bn 43.79 Bn - -
8 Incyte 25.23 Bn 20.69 Bn 1.57 Bn -
9 United Therapeutics 21.67 Bn 19.01 Bn 683.80 Mn -
10 Trafalgar International 217,335.05 217,335.05 - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 36,000.00
Sep 30, 2022 135,000.00
Jun 30, 2022 25,000.00
Sep 30, 2021 311,050.00
Jun 30, 2021 67,082.00
Mar 31, 2021 22,500.00
Dec 31, 2020 325,212.00
Sep 30, 2020 311,050.00
Jun 30, 2020 67,082.00
Mar 31, 2020 165,350.00